Praveen Kumar, PhD
V.P. Drug Development
Ph.D., M.Sc. (Clinical Chemistry), M. Pharm, B. Pharm
Praveen has experience working in the pharmaceutical industry for more than 25
years and has expertise in the development of drug products for small and macro-molecules using various dosage forms. He was involved in projects comprising the formulation development of generic drug products and their production and developed a novel transdermal drug product containing a protein-based drug (interferon alpha 2b) for the treatment of HPV infections.
Presently as a V.P. he manages the CMC-related activities (drug product formulation,
technology transfer, quality, stability testing and interaction with regulatory agency) for the development of L-DOS47 drug product, an antibody drug conjugate, for the treatment of various cancers. He has a Ph.D. in Pharmaceutical sciences and he completed his post-doctoral fellowship in gene regulation. He was the author of multiple peer-reviewed published articles, a book chapter, and patents.